Publications by authors named "Nancy Klemm"

Claim this Profile
T
The pathogenesis of therapy-related myeloid neoplasms from TP53-mutant clonal hematopoiesis.
Jonas Fullin, Ebru Topçu, Karolina A Zielińska, Roman R Schimmer, Nancy Klemm

Leukemia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative Effect.
Nancy Klemm, Roman R Schimmer, Nils K Konrad, Flavian Thelen, Jonas Fullin

Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells.
Jan Mueller, Roman R Schimmer, Christian Koch, Florin Schneiter, Jonas Fullin, Nancy Klemm

EMBO Mol Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic balance in colorectal cancer is maintained by optimal Wnt signaling levels.
Katharina Imkeller, Giulia Ambrosi, Nancy Klemm, Ainara Claveras Cabezudo, Luisa Henkel

Mol Syst Biol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms.
Roman R Schimmer, Larisa V Kovtonyuk, Nancy Klemm, Jonas Fullin, Sebastian M Stolz

Blood Adv· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of accuracy and precision between multipoint calibration, single point calibration, and relative quantification for targeted metabolomic analysis.
Mona M Khamis, Nancy Klemm, Darryl J Adamko, Anas El-Aneed

Anal Bioanal Chem· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis